Skip to search boxSkip to navigationSkip to main content

Detailed investigations of 5-HT3 compounds in a drug discrimination model

  • Richard De La Garza
    ,
  • Patrick M. Callahan
    ,
  • Kathryn A. Cunningham(corresponding author)
*Corresponding author for this work
  • University of Texas Medical Branch at Galveston
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Serotonin type-3 (5-HT3) receptors modulate both dopamine (DA) release and locomotor stimulation induced by cocaine, yet appear to be ineffective at blocking its stimulus and reinforcing effects. To more thoroughly characterize a potential modulatory role of 5-HT3 receptors in the stimulus effects of cocaine, rats (n = 8/group) were trained to discriminate cocaine (10 mg/kg, IP) or the 5-HT3 agonist 1-(meta-chlorophenyl)-biguanide (mCPBG: 15 mg/kg, IP) from saline using a standard drug discrimination task. In rats trained to discriminate cocaine, mCPBG (2.5-20 mg/kg) produced, at best, a partial substitution while mCPBG (10 mg/kg) did not alter the cocaine dose- response relationship. The 5-HT3 antagonists MDL 72222 (10 mg/kg) and ondansetron (1.25-16 mg/kg) did not attenuate the cocaine cue. In rats trained to discriminate mCPBG from saline, the 5-HT precursor l-5- hydroxytryptophan (12.5-50 mg/kg) dose-dependently substituted for mCPBG, whereas the 5-HT3 antagonist zacopride (0.1-10 mg/kg) partially antagonized the mCPBG cue, demonstrating that mCPBG produces distinct discriminable effects that appear to be mediated by 5-HT, possibly 5-HT3, receptors. However, cocaine (5-20 mg/kg) did not substitute in mCPBG-trained rats. Overall, these data support previous findings to suggest that 5-HT3 receptors play little role in mediating the discriminative stimulus effects of cocaine and suggest that the neurochemical mechanisms and/or sites of action important for the generation of the discriminative stimulus vs. locomotor stimulatory effects of cocaine may he dissociable.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 533-540 (8 pages)

Journal (Volume, Issue Number)

Pharmacology Biochemistry and Behavior (Volume 54, Issue 3)

Publication milestones

  • Published - 07/1996

Publication status

Published - 07/1996

ISSN

0091-3057

Publication IDs

  • Scopus: 0029942974
  • PubMed: 8743626

Publication metrics

Metrics

SciVal
FWCI
1.32
SciVal
Author count
3
SciVal
citations
25
SciVal
Paper percentile
77
Scopus
citations
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
27
Captures
8

Funding Details

The research described herein was supported by the National Institute on Drug Abuse Grants DA05708 and DA06511 (K.A.C.), and DA05638 (R.D.).